ISPUB.com / IJDS/12/1/2951
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Dental Science
  • Volume 12
  • Number 1

Review

Decision-Making In The Periodontal Practice Regarding Periodontal Risk Factors

A Dannan

Keywords

diabetes, periodontitis, risk factor, tobacco smoking

Citation

A Dannan. Decision-Making In The Periodontal Practice Regarding Periodontal Risk Factors. The Internet Journal of Dental Science. 2013 Volume 12 Number 1.

Abstract

The identification of groups and individuals at risk for disease progression still represents one of the greatest challenges in the management of periodontal patients.
Tobacco smoking, poor-controlled diabetes mellitus (both type 1 and type 2), specific pathogenic bacteria, microbial tooth deposits, genetic factors, age, gender, socioeconomic status, stress, infection with Human Immunodeficiency Virus (HIV), and osteoporosis are all considered to be risk "elements" for periodontal disease.
In this paper, we tried to introduce a simple method for systematic decision making in the periodontal practice regarding the most accepted periodontal risk factors. A fundamental review of risk factors in Periodontology has also been conducted.

 

Introduction

The role of risk factors and risk assessment in the prediction of clinical periodontal outcomes has been a subject of much interest. To date, it is accepted that specific pathogenic bacteria (A.a, P.g, B.f), cigarette smoking, and diabetes mellitus are the major established risk factors for periodontitis. Although several approaches have been developed to assess the factors which may interfere with periodontal disease’s onset and/or progression, some contradictions regarding the classification, the definition, and the assumed implemented factors do exist among all these methods.
Risk assessment can be defined by numerous components (1, 2).
Risk is the probability that an individual will develop a specific disease in a given period. The risk of developing the disease will vary from individual to individual.
A risk factor can be defined as any environmental, behavioral, or biologic factor that, when present, increases the likelihood that an individual will develop the disease (3). It is important to make the distinction that risk factors are associated with a disease but do not necessarily cause the disease. Evidence used to identify risk factors is usually derived from case reports, case series, case-control study, cross-sectional studies, longitudinal cohort studies, and controlled clinical trials, also known as interventional studies. All of these studies can identify factors associated with a disease though they are not equal in strength. The longitudinal study may be capable of identifying a causal relationship. The interventional study gives the strongest evidence of a causal relationship and furthermore can provide evidence of the benefit of eliminating the risk factor (4).
However, to be identified as a risk factor, the exposure must occur before disease onset.
The term risk determinant is reserved to those risk factors that cannot be modified.
Risk indicators are probable risk factors that have been identified in cross-sectional studies but not confirmed through longitudinal studies.
Risk markers, although associated with increased risk for disease, do not cause the disease.
In a recent paper (5), we initiated the term "Risk Elements" due to the contradiction found in the literature regarding how to define and classify risk factors, risk determinants, risk indicators, and risk markers for periodontal disease.

Risk

While the current understanding of risk elements associated with periodontitis has expanded, the identification of groups and individuals at risk for disease progression still represents one of the greatest challenges in the management of periodontal patients.
Most accepted risk elements for periodontal disease include tobacco smoking, poor-controlled diabetes mellitus (both type 1 and type 2), specific pathogenic bacteria, microbial tooth deposits, genetic factors, age, gender, socioeconomic status, stress, infection with Human Immunodeficiency Virus (HIV), and osteoporosis.


Smoking
Cigarette smoking is recognized as a major risk factor in the incidence and progression of periodontitis (6-12). A dose-effect relationship between cigarette smoking and the severity of periodontitis has also been demonstrated (12-16). Odds ratios for developing periodontal disease as a result of smoking range from 2.5 (17), 3.97 for current smokers and 1.68 for former smokers (12) and 3.25 for light smokers to 7.28 for heavy smokers (15). Clinical studies have indicated that smokers respond less favourably to periodontal treatment compared with non-smokers (18-21).
Moreover, a significant effect of smoking on bone height reduction was observed. It was suggested that there is an accelerated height reduction rate for smokers compared with non-smokers as found by Paulander et al. (2004) (22) in a 10-year prospective study of a randomized sample of 50-year-old individuals, where the incidence of periodontal bone loss and potential risk factors for periodontal bone loss were analyzed. Smoking was found to be the strongest risk predictor for alveolar bone loss during the 10-year period. The relative risk for bone loss was 3.2 for smokers compared with never smokers. Subjects who had quit smoking before the baseline examination did not demonstrate an increased risk for disease progression.
While non-smokers and former smokers (more than 5 years since cessation) have a relatively low risk for recurrence of periodontitis, the heavy smokers (as defined by smoking more than one pack per day) are definitely at high risk. Occasional smokers (< 10 cigarettes a day) and moderate smokers (10-19 cigarettes a day) may be considered at moderate risk for disease progression (23).
In conclusion, cigarette smoking represents a risk factor for progression of periodontitis, the effect of which may be dose related. Heavy smokers should be considered as high-risk individuals for disease progression. The clinical implications for this are that smokers should be identified during patient examination and efforts should be made to modify this behavioural risk factor.


Poor-controlled diabetes mellitus
Although studies that have examined the relationship between diabetes and periodontitis are heterogenous in design and aim, current studies support a higher incidence and severity of periodontitis in patients with diabetes mellitus (24, 25).
A review of the literature by Kinane and Chestnutt (1997) found considerable evidence to suggest that diabetes and periodontitis have a direct relationship (26). Studies have shown a relationship between poor glycemic control and periodontal disease parameters (27-30). Taylor (2001) has suggested a bi-directional relationship between periodontal disease and glycemic control (31) with each disease having a potential impact on the other.
Cross sectional studies on Pima Indians, a group displaying the highest prevalence of type 2 diabetes in the world, show an odds ratio of 2.8 to 3.4 for developing periodontal disease in type 2 diabetics compared to non-diabetics (32). Similarly, longitudinal studies have shown increased risk of ongoing periodontal destruction in diabetics as compared to non-diabetics with an odds ratio of 4.2. Finally, studies have been done which suggest that poorly controlled diabetics respond less successfully to periodontal therapy relative to well-controlled and non-diabetics (33, 34).
Although no difference in impact has been determined between type 1 and type 2 diabetes mellitus in general (35), it has been recently shown that type 2 could be more connected to periodontitis, as a risk factor, and that more studies are still needed to confirm the harmful effects of type 1 diabetes mellitus on periodontal disease (36). 
In conclusion, studies indicate that diabetics with poor glycemic control have an increased risk for periodontitis and disease progression. Preventive periodontal regimens for diabetic patients should be sufficiently intense and sustained to eliminate periodontal inflammation and should be closely coordinated with the patient's overall clinical diabetic management (37).


Pathogenic bacteria and microbial tooth deposits
Although there are over 500 different intra-oral species and others that have not yet been identified, the majority of studies have focused on a subset of microorganisms including Aggregatibacter actinomycetemcomitans (A.a) (formerly Actinobacillus actinomycetemcomitans), P. gingivalis (P.g), Tanerella forsythensis (T.f) (formerly Bacteroides forsythus (B.f), Prevotella intermedia (P.i), and Treponema denticola (T.d).
However, of all of the various microorganisms that colonize the mouth, there are three; Porphyromonas gingivalis, Tannerella forsythia, and Aggregatibacter actinomycetemcomitans have been implicated as etiologic agents in periodontitis. The presence of periodontal pathogens, though necessary to cause disease, is not sufficient. Indeed the odds ratio of developing periodontal disease in an individual who harbors one of the putative periodontal pathogens is not high enough to consider them a risk factor (38).
Papapanou et al. (1997) (39) studied subgingival microbiota in an untreated Chinese population and found an association between subjects with progressing tooth sites and certain bacteria (P.g, T.f, T.d). Albandar et al. (1997) (40) found an association between individuals with rapid disease progression and specific bacterial species (P.g, T.d, P.i). In both these studies (39, 40), the microbiological sampling was performed at the end of the time period over which the clinical disease progression was assessed.
A number of longitudinal studies have shown that the presence and elevated levels of one or more of these species at baseline are a prognostic indicator for disease progression (increased attachment loss or bone loss) (11, 41-44). Other studies do not support the detection of specific bacterial species for the identification of individuals at risk for periodontitis progression (45-47). While the majority of the periodontal microbiota is commensally, a subset of likely opportunistic pathogens fulfills the epidemiologic requirements needed in order to be ascribed as risk/causative factors. Given the large proportion of the periodontal microbial habitat that is currently insufficiently explored, and assuming that the hitherto uncultivated segment of the bacterial community will include similar levels of pathogenic species, the list of periodontal pathogens should be expected to expand (48).
On an individual level, longitudinal studies have shown that plaque scores are a poor predictor of periodontitis progression (41, 49). However, Nyman et al. (1977) (50) showed that patients with high plaque scores had greater periodontitis progression following periodontal surgery than untreated periodontal patients. A number of longitudinal studies have demonstrated that patients who do not comply with regular periodontal maintenance experience greater progression of disease (51-53).


Stress and socioeconomic status
Studies have demonstrated that individuals under psychological stress are more likely to develop clinical attachment loss and loss of alveolar bone (54-58). One possible link in this regard may be increases in production of Interleukin (IL)-6 in response to increased psychological stress. Another study suggests that host response to P. gingivalis infection may be compromised in psychologically stressed individuals (59).
Gingivitis and poor oral hygiene have been shown to be related to lower socioeconomic status (1). This can most likely be attributed to decreased dental awareness and decreased frequency of dental visits. After adjusting for other risk factors, lower socioeconomic status alone does not result in increased risk for periodontitis. Similarly, evidence for the role of stress and depression in modifying an individual’s susceptibility to periodontitis progression is limited and inconclusive (3, 60). It is difficult to distinguish between the roles that stress plays on host resistance factors and altered behavioural responses that stress may induce, such as negligence in oral hygiene and increased smoking. The significance of stress and coping behaviours on periodontitis progression requires further investigation.


Genetic factors and host response 
Evidence indicates that genetic differences between individuals may explain why some patients develop periodontal disease and others do not. Studies of identical twins suggest 50% of susceptibility to periodontal disease is due to host factors (61).
It has been also indicated through evidence that the destruction observed in periodontal disease is the result of an improperly regulated immune response to bacterial infection rather than the directly destructive effect of the bacterial pathogens themselves (62). In the case of localized aggressive periodontitis, it has been suggested that overly active or “primed” neutrophils may be responsible for mediating much the tissue destruction that is observe in that disease (62).
IL-1 gene polymorphisms have been linked to periodontal disease. Thus specific IL-1 genotypes have been linked to the presence of pathogenic microorganisms (63), and to an increased risk of periodontal diseases in non-smokers (64) and smokers (65, 66). In a population studied by Kornman et al. (1997) (64), an odds ration of 18.9 was associated with a specific IL-1 genotype.
Meisel et al. (2002) (66) have shown results that demonstrate no effect of IL-1 genotype in non-smokers. Guzman et al. (2003) (28) have shown a possible relationship between IL-1 genotype and periodontal status in diabetics, while, more recently, Lopez et al. found that although periodontitis was significantly associated with some IL-1 gene polymorphisms, no association between diabetes and IL-1A and -1B gene polymorphisms was found (67).
According to a recent meta-analysis study (68), a statistically significant association of IL-1A C[-889]T and IL-1B C[3953/4]T polymorphisms was found with chronic periodontal disease. A weak positive association was also found concerning IL-1B T[-511]C and chronic periodontal disease, and no association was found for all the cytokines examined as far as the aggressive form of the disease is concerned.
It seems to be that no definitive IL-1 genotype exists that puts individuals in any given population at risk for periodontal disease. Furthermore, the evidence suggesting possible interactions between IL-1 and smoking and diabetes suggest that there is interplay between genetic an environmental factors that results in periodontal disease.


Age
Ageing is associated with an increased incidence of periodontal disease (9, 15). However it has been suggested that the increased level of periodontal destruction observed with aging is the result of cumulative destruction rather than a result of increased rates of destruction. A recent review (69) has shown that aging alone does not lead to critical loss of periodontal attachment in healthy elderly persons and that the effects of aging on periodontal tissues are based on molecular changes in the periodontal cells, which intensify bone loss in elderly patients with periodontitis. These effects may be associated with alterations in differentiation and proliferation of osteoblasts and osteoclasts, an increase in periodontal cell response to the oral microbiota and mechanical stress leading to the secretion of cytokines involved in osseous resorption, and systemic endocrine alterations in the elderly people.
Thus aging is not a risk factor per se (70).


Gender
Epidemiological surveys show a higher prevalence and extent of attachment loss in males than females (71). Hyman and Reid (2003) (10), in a study of epidemiological risk factors for periodontal attachment loss among adults, found, after adjustment for confounding variables, that males were at increased risk of attachment loss. Attachment loss thresholds of ≥3, ≥4, ≥5mm were noted in 23%, 44% and 55% more males than females, respectively. It has been suggested that hormonal and behavioural differences including differences in oral hygiene between the two gender groups may contribute to the higher risk for periodontitis in males than females (71).


Osteoporosis
Osteoporosis, characterized by a decrease in bone mineral density (BMD), is a common metabolic bone disease among the elderly. The association between systemic osteoporosis and periodontitis has been investigated in cross-sectional studies with conflicting results. Some studies indicate osteoporosis as a risk indicator for periodontitis (72, 73), while others do not find a significant association (74, 75). As both periodontitis and osteoporosis result in bone loss and share common risk factors, it has been suggested that postmenopausal women with osteoporosis (low skeletal BMD) may be at risk for progression of periodontitis (76, 77).
There are only a limited number of longitudinal studies evaluating the association of osteoporosis and periodontitis progression. In a 2-year longitudinal clinical study, Payne et al. (1999) (78) found greater alveolar bone loss in osteoporotic and estrogen-deficient women. All subjects were non-smokers.
Another longitudinal study including 179 subjects (non-smokers) found, after adjustment for confounding variables, a weak but significant relationship between additional attachment loss (≥3 mm) and systemic BMD over a 3-year period in an older (70 years) Japanese population (79). Another study found also little evidence of an association between periodontitis and skeletal BMD among older men (80).
The relationship between osteoporosis and periodontitis remains unclear. Larger prospective longitudinal studies are needed to further evaluate osteoporosis as a risk factor for progressive periodontitis.


Human immunodeficiency virus infection
Two longitudinal cohort studies have documented an accelerated rate of attachment loss in HIV seropositive patients (81, 82). A recent longitudinal evaluation of prostaglandin E2 (PGE2) and periodontal status in HIV+ patients indicated that sites with high gingival crevicular fluid levels of PGE2 in HIV+ patients are at significantly greater risk for progression of periodontitis (83).
More recently, a hypothetic model about the potential role of periodontitis as a global oral infection that potentially contributes to HIV recrudescence has been presented (84).
However, other studies that attempted to eliminate selection bias (85, 86) showed no differences in baseline attachment loss between HIV-seropositive and -seronegative controls. Indeed, rates of disease progression were recorded at only 1% over the observation period. Similar data have emerged from Robinson et al. (2000) (87), who found no difference in disease progression, as measured by relative attachment loss on six index teeth, between 19 HIV-positive and 17 HIV-negative individuals over a 12-month period.
To conclude, current evidence suggests that HIV seropositivity is not a predictor for progressive periodontitis.

A systematic decision making in the periodontal practice

Depending on the recent agreement of accepting specific bacteria (A.a, P.g, B.f), cigarette smoking, and diabetes mellitus as the major established risk factors for periodontitis (88), we tried to develop a simple scheme for systematic decision making in the periodontal practice (Fig. 1).

Figure 1

Systematic decision making in the periodontal practice

As usual, the first step would be a fundamental examination of the periodontal status and finally making an appropriate diagnosis of the periodontal disease. The next step would be the assessment of current risk elements for periodontal disease. Here, if one or more of the major risk factors (i.e. detection of perio-pathogenic bacteria, heavy cigarette smoking, or diabetes) is proved to be available, the patient would be directly considered as “high-risk patient”, and a modification of the whole treatment plan is obligatory. If this is not the case, other possible risk elements should be distinguished. In this contest, a distinction between risk determinants and risk indicators is made according to Novak and Novak (3). If one or more of risk determinants does exist, the patient would be considered as “moderate-risk patient”, and a modification of the whole treatment plan might be necessary according to every individual case.
If one or more of risk indicators does exist, the patient would be considered as “low-risk patient”. In this case, a modification of the whole treatment plan might be necessary.
For instance, a diabetic heavy smoker male patient who suffers from chronic periodontitis with a history of stress and poor oral hygiene would be considered as “high-risk patient”, and the treatment plan would probably concentrate on non-surgical method with adjunctive antibiotics rather than surgical methods and regenerative applications (e.g. using enamel matrix derivatives). Moreover, in such cases, the patient should be carefully educated about the importance of later supportive periodontal therapy with restricted recall visits (i.e. minimum 4 times/ year).
Another female patient who is a former smoker (more than 5 years since cessation) and suffers from chronic periodontitis with a current history of osteoporosis and very good oral hygiene would be considered as “low-risk patient” at the dental clinic. In such a case, almost all periodontal treatment methods are applicable, and normal recall visits are required (i.e. up to 2 times/ year).

Summary

To date, most accepted risk elements for periodontal disease include tobacco smoking, poor-controlled diabetes mellitus (both type 1 and type 2), specific pathogenic bacteria, microbial tooth deposits, genetic factors, age, gender, socioeconomic status, stress, infection with Human Immunodeficiency Virus, and osteoporosis.
Taking such risk elements in the daily periodontal practice should be mandatory, since this may change or modify the treatment plan.
The scheme of systematic decision making in the periodontal treatment which has been introduced in this paper could be appointed at the dental office, at the periodontal disease treatment centers, and at dental schools. However, this may require careful following to assure the certainty of application.

References

1. Position paper: epidemiology of periodontal diseases. American Academy of Periodontology. J Periodontol. 1996 Sep;67(9):935-45. PubMed PMID: 8884652. Epub 1996/09/01. eng.
2. Page RC, Beck JD. Risk assessment for periodontal diseases. Int Dent J. 1997 Apr;47(2):61-87. PubMed PMID: 9448791. Epub 1997/04/01. eng.
3. Novak K, Novak M. Risk Assessment. In: Newman MG, Takei HH, Klokkevold PR, Carranza FA, editors. Carranza's Clinical Periodontology. 10 ed. St. Louis, Missouri: Elsevier Inc; 2006. p. 602-8.
4. Van Dyke TE, Sheilesh D. Risk factors for periodontitis. J Int Acad Periodontol. 2005 Jan;7(1):3-7. PubMed PMID: 15736889. Epub 2005/03/02. eng.
5. Dannan A. Periodontal Risk Assessment; Are we on the right Track? Archives of Oral Sciences & Research. 2011;1(3):162-7.
6. Beck JD, Koch GG, Rozier RG, Tudor GE. Prevalence and risk indicators for periodontal attachment loss in a population of older community-dwelling blacks and whites. J Periodontol. 1990 Aug;61(8):521-8. PubMed PMID: 2391631. Epub 1990/08/01. eng.
7. Laxman VK, Annaji S. Tobacco use and its effects on the periodontium and periodontal therapy. J Contemp Dent Pract. 2008;9(7):97-107. PubMed PMID: 18997922. Epub 2008/11/11. eng.
8. Bergstrom J, Preber H. Tobacco use as a risk factor. J Periodontol. 1994 May;65(5 Suppl):545-50. PubMed PMID: 8046571. Epub 1994/05/01. eng.
9. Grossi SG, Zambon JJ, Ho AW, Koch G, Dunford RG, Machtei EE, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol. 1994 Mar;65(3):260-7. PubMed PMID: 8164120. Epub 1994/03/01. eng.
10. Hyman JJ, Reid BC. Epidemiologic risk factors for periodontal attachment loss among adults in the United States. J Clin Periodontol. 2003 Mar;30(3):230-7. PubMed PMID: 12631181. Epub 2003/03/13. eng.
11. Machtei EE, Dunford R, Hausmann E, Grossi SG, Powell J, Cummins D, et al. Longitudinal study of prognostic factors in established periodontitis patients. J Clin Periodontol. 1997 Feb;24(2):102-9. PubMed PMID: 9062856. Epub 1997/02/01. eng.
12. Tomar SL, Asma S. Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol. 2000 May;71(5):743-51. PubMed PMID: 10872955. Epub 2000/06/29. eng.
13. Bergstrom J, Eliasson S, Dock J. A 10-year prospective study of tobacco smoking and periodontal health. J Periodontol. 2000 Aug;71(8):1338-47. PubMed PMID: 10972650. Epub 2000/09/06. eng.
14. Calsina G, Ramon JM, Echeverria JJ. Effects of smoking on periodontal tissues. J Clin Periodontol. 2002 Aug;29(8):771-6. PubMed PMID: 12390575. Epub 2002/10/23. eng.
15. Grossi SG, Genco RJ, Machtei EE, Ho AW, Koch G, Dunford R, et al. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol. 1995 Jan;66(1):23-9. PubMed PMID: 7891246. Epub 1995/01/01. eng.
16. Meisel P, Schwahn C, Gesch D, Bernhardt O, John U, Kocher T. Dose-effect relation of smoking and the interleukin-1 gene polymorphism in periodontal disease. J Periodontol. 2004 Feb;75(2):236-42. PubMed PMID: 15068111. Epub 2004/04/08. eng.
17. Bergstrom J. Cigarette smoking as risk factor in chronic periodontal disease. Community Dent Oral Epidemiol. 1989 Oct;17(5):245-7. PubMed PMID: 2791514. Epub 1989/10/01. eng.
18. Cortellini P, Tonetti MS. Long-term tooth survival following regenerative treatment of intrabony defects. J Periodontol. 2004 May;75(5):672-8. PubMed PMID: 15212349. Epub 2004/06/24. eng.
19. Chambrone L, Chambrone D, Pustiglioni FE, Chambrone LA, Lima LA. The influence of tobacco smoking on the outcomes achieved by root-coverage procedures: a systematic review. J Am Dent Assoc. 2009 Mar;140(3):294-306. PubMed PMID: 19255173. Epub 2009/03/04. eng.
20. Preber H, Bergstrom J. Effect of cigarette smoking on periodontal healing following surgical therapy. J Clin Periodontol. 1990 May;17(5):324-8. PubMed PMID: 2355098. Epub 1990/05/01. eng.
21. Tonetti MS, Pini-Prato G, Cortellini P. Effect of cigarette smoking on periodontal healing following GTR in infrabony defects. A preliminary retrospective study. J Clin Periodontol. 1995 Mar;22(3):229-34. PubMed PMID: 7790529. Epub 1995/03/01. eng.
22. Paulander J, Wennstrom JL, Axelsson P, Lindhe J. Some risk factors for periodontal bone loss in 50-year-old individuals. A 10-year cohort study. J Clin Periodontol. 2004 Jul;31(7):489-96. PubMed PMID: 15191581. Epub 2004/06/12. eng.
23. Lang NP, Tonetti MS. Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT). Oral Health Prev Dent. 2003;1(1):7-16. PubMed PMID: 15643744. Epub 2005/01/13. eng.
24. Sandberg GE, Sundberg HE, Fjellstrom CA, Wikblad KF. Type 2 diabetes and oral health: a comparison between diabetic and non-diabetic subjects. Diabetes Res Clin Pract. 2000 Sep;50(1):27-34. PubMed PMID: 10936666. Epub 2000/08/11. eng.
25. Soskolne WA, Klinger A. The relationship between periodontal diseases and diabetes: an overview. Ann Periodontol. 2001 Dec;6(1):91-8. PubMed PMID: 11887477. Epub 2002/03/13. eng.
26. Kinane DF, Chestnutt IG. Relationship of diabetes to periodontitis. Curr Opin Periodontol. 1997;4:29-34. PubMed PMID: 9655018. Epub 1997/01/01. eng.
27. Cutler CW, Machen RL, Jotwani R, Iacopino AM. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. J Periodontol. 1999 Nov;70(11):1313-21. PubMed PMID: 10588494. Epub 1999/12/10. eng.
28. Guzman S, Karima M, Wang HY, Van Dyke TE. Association between interleukin-1 genotype and periodontal disease in a diabetic population. J Periodontol. 2003 Aug;74(8):1183-90. PubMed PMID: 14514232. Epub 2003/09/30. eng.
29. Tervonen T, Oliver RC, Wolff LF, Bereuter J, Anderson L, Aeppli DM. Prevalence of periodontal pathogens with varying metabolic control of diabetes mellitus. J Clin Periodontol. 1994 Jul;21(6):375-9. PubMed PMID: 8089237. Epub 1994/07/01. eng.
30. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol. 2002 Jun;30(3):182-92. PubMed PMID: 12000341. Epub 2002/05/10. eng.
31. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol. 2001 Dec;6(1):99-112. PubMed PMID: 11887478. Epub 2002/03/13. eng.
32. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol. 1991 Feb;62(2):123-31. PubMed PMID: 2027060. Epub 1991/02/01. eng.
33. Tervonen T, Karjalainen K. Periodontal disease related to diabetic status. A pilot study of the response to periodontal therapy in type 1 diabetes. J Clin Periodontol. 1997 Jul;24(7):505-10. PubMed PMID: 9226392. Epub 1997/07/01. eng.
34. Westfelt E, Rylander H, Blohme G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol. 1996 Feb;23(2):92-100. PubMed PMID: 8849844. Epub 1996/02/01. eng.
35. Heitz-Mayfield LJ. Disease progression: identification of high-risk groups and individuals for periodontitis. J Clin Periodontol. 2005;32 Suppl 6:196-209. PubMed PMID: 16128838. Epub 2005/09/01. eng.
36. Chavarry NG, Vettore MV, Sansone C, Sheiham A. The relationship between diabetes mellitus and destructive periodontal disease: a meta-analysis. Oral Health Prev Dent. 2009;7(2):107-27. PubMed PMID: 19583037. Epub 2009/07/09. eng.
37. Madden TE, Herriges B, Boyd LD, Laughlin G, Chiodo G, Rosenstein D. Alterations in HbA1c following minimal or enhanced non-surgical, non-antibiotic treatment of gingivitis or mild periodontitis in type 2 diabetic patients: a pilot trial. J Contemp Dent Pract. 2008;9(5):9-16. PubMed PMID: 18633464. Epub 2008/07/18. eng.
38. Ezzo PJ, Cutler CW. Microorganisms as risk indicators for periodontal disease. Periodontol 2000. 2003;32:24-35. PubMed PMID: 12756031. Epub 2003/05/21. eng.
39. Papapanou PN, Baelum V, Luan WM, Madianos PN, Chen X, Fejerskov O, et al. Subgingival microbiota in adult Chinese: prevalence and relation to periodontal disease progression. J Periodontol. 1997 Jul;68(7):651-66. PubMed PMID: 9249637. Epub 1997/07/01. eng.
40. Albandar JM, Brown LJ, Loe H. Putative periodontal pathogens in subgingival plaque of young adults with and without early-onset periodontitis. J Periodontol. 1997 Oct;68(10):973-81. PubMed PMID: 9358364. Epub 1997/11/14. eng.
41. Haffajee AD, Socransky SS, Lindhe J, Kent RL, Okamoto H, Yoneyama T. Clinical risk indicators for periodontal attachment loss. J Clin Periodontol. 1991 Feb;18(2):117-25. PubMed PMID: 2005225. Epub 1991/02/01. eng.
42. Machtei EE, Hausmann E, Dunford R, Grossi S, Ho A, Davis G, et al. Longitudinal study of predictive factors for periodontal disease and tooth loss. J Clin Periodontol. 1999 Jun;26(6):374-80. PubMed PMID: 10382577. Epub 1999/06/26. eng.
43. Timmerman MF, Van der Weijden GA, Abbas F, Arief EM, Armand S, Winkel EG, et al. Untreated periodontal disease in Indonesian adolescents. Longitudinal clinical data and prospective clinical and microbiological risk assessment. J Clin Periodontol. 2000 Dec;27(12):932-42. PubMed PMID: 11140561. Epub 2001/01/05. eng.
44. Tran SD, Rudney JD, Sparks BS, Hodges JS. Persistent presence of Bacteroides forsythus as a risk factor for attachment loss in a population with low prevalence and severity of adult periodontitis. J Periodontol. 2001 Jan;72(1):1-10. PubMed PMID: 11210065. Epub 2001/02/24. eng.
45. Buchmann R, Muller RF, Heinecke A, Lange DE. Actinobacillus actinomycetemcomitans in destructive periodontal disease. Three-year follow-up results. J Periodontol. 2000 Mar;71(3):444-53. PubMed PMID: 10776933. Epub 2000/04/25. eng.
46. Listgarten MA, Slots J, Nowotny AH, Oler J, Rosenberg J, Gregor B, et al. Incidence of periodontitis recurrence in treated patients with and without cultivable Actinobacillus actinomycetemcomitans, Prevotella intermedia, and Porphyromonas gingivalis: a prospective study. J Periodontol. 1991 Jun;62(6):377-86. PubMed PMID: 1870068. Epub 1991/06/01. eng.
47. Wennstrom JL, Dahlen G, Svensson J, Nyman S. Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius: predictors of attachment loss? Oral Microbiol Immunol. 1987 Dec;2(4):158-62. PubMed PMID: 3507628. Epub 1987/12/01. eng.
48. Papapanou PN. Population studies of microbial ecology in periodontal health and disease. Ann Periodontol. 2002 Dec;7(1):54-61. PubMed PMID: 16013217. Epub 2005/07/15. eng.
49. Kaldahl WB, Kalkwarf KL, Patil KD, Molvar MP. Relationship of gingival bleeding, gingival suppuration, and supragingival plaque to attachment loss. J Periodontol. 1990 Jun;61(6):347-51. PubMed PMID: 2195151. Epub 1990/06/01. eng.
50. Nyman S, Lindhe J, Rosling B. Periodontal surgery in plaque-infected dentitions. J Clin Periodontol. 1977 Nov;4(4):240-9. PubMed PMID: 340476. Epub 1977/11/01. eng.
51. Becker W, Becker BE, Berg LE. Periodontal treatment without maintenance. A retrospective study in 44 patients. J Periodontol. 1984 Sep;55(9):505-9. PubMed PMID: 6592322. Epub 1984/09/01. eng.
52. Nyman S, Rosling B, Lindhe J. Effect of professional tooth cleaning on healing after periodontal surgery. J Clin Periodontol. 1975 Apr;2(2):80-6. PubMed PMID: 1094035. Epub 1975/04/01. eng.
53. Wilson TG, Jr., Glover ME, Malik AK, Schoen JA, Dorsett D. Tooth loss in maintenance patients in a private periodontal practice. J Periodontol. 1987 Apr;58(4):231-5. PubMed PMID: 3295181. Epub 1987/04/01. eng.
54. Hugoson A, Ljungquist B, Breivik T. The relationship of some negative events and psychological factors to periodontal disease in an adult Swedish population 50 to 80 years of age. J Clin Periodontol. 2002 Mar;29(3):247-53. PubMed PMID: 11940145. Epub 2002/04/10. eng.
55. Peruzzo DC, Benatti BB, Ambrosano GM, Nogueira-Filho GR, Sallum EA, Casati MZ, et al. A systematic review of stress and psychological factors as possible risk factors for periodontal disease. J Periodontol. 2007 Aug;78(8):1491-504. PubMed PMID: 17668968. Epub 2007/08/03. eng.
56. Mawhorter SD, Lauer MA. Is atherosclerosis an infectious disease? Cleve Clin J Med. 2001 May;68(5):449-58. PubMed PMID: 11352325. Epub 2001/05/16. eng.
57. Pistorius A, Krahwinkel T, Willershausen B, Boekstegen C. Relationship between stress factors and periodontal disease. Eur J Med Res. 2002 Sep 30;7(9):393-8. PubMed PMID: 12435617. Epub 2002/11/19. eng.
58. Wimmer G, Janda M, Wieselmann-Penkner K, Jakse N, Polansky R, Pertl C. Coping with stress: its influence on periodontal disease. J Periodontol. 2002 Nov;73(11):1343-51. PubMed PMID: 12479640. Epub 2002/12/14. eng.
59. Houri-Haddad Y, Itzchaki O, Ben-Nathan D, Shapira L. The effect of chronic emotional stress on the humoral immune response to Porphyromonas gingivalis in mice. J Periodontal Res. 2003 Apr;38(2):204-9. PubMed PMID: 12608916. Epub 2003/03/01. eng.
60. Rosania AE, Low KG, McCormick CM, Rosania DA. Stress, depression, cortisol, and periodontal disease. J Periodontol. 2009 Feb;80(2):260-6. PubMed PMID: 19186966. Epub 2009/02/04. eng.
61. Michalowicz BS, Diehl SR, Gunsolley JC, Sparks BS, Brooks CN, Koertge TE, et al. Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol. 2000 Nov;71(11):1699-707. PubMed PMID: 11128917. Epub 2000/12/29. eng.
62. Van Dyke TE, Serhan CN. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res. 2003 Feb;82(2):82-90. PubMed PMID: 12562878. Epub 2003/02/04. eng.
63. Socransky SS, Haffajee AD, Smith C, Duff GW. Microbiological parameters associated with IL-1 gene polymorphisms in periodontitis patients. J Clin Periodontol. 2000 Nov;27(11):810-8. PubMed PMID: 11073323. Epub 2000/11/10. eng.
64. Kornman KS, Crane A, Wang HY, di Giovine FS, Newman MG, Pirk FW, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol. 1997 Jan;24(1):72-7. PubMed PMID: 9049801. Epub 1997/01/01. eng.
65. Meisel P, Kocher T. Risk factors in periodontitis and classifying the disease. Eur J Oral Sci. 2003 Jun;111(3):280-1; author reply 2-3. PubMed PMID: 12786962. Epub 2003/06/06. eng.
66. Meisel P, Siegemund A, Dombrowa S, Sawaf H, Fanghaenel J, Kocher T. Smoking and polymorphisms of the interleukin-1 gene cluster (IL-1alpha, IL-1beta, and IL-1RN) in patients with periodontal disease. J Periodontol. 2002 Jan;73(1):27-32. PubMed PMID: 11846196. Epub 2002/02/16. eng.
67. Lopez NJ, Valenzuela CY, Jara L. Interleukin-1 gene cluster polymorphisms associated with periodontal disease in type 2 diabetes. J Periodontol. 2009 Oct;80(10):1590-8. PubMed PMID: 19792847. Epub 2009/10/02. eng.
68. Nikolopoulos GK, Dimou NL, Hamodrakas SJ, Bagos PG. Cytokine gene polymorphisms in periodontal disease: a meta-analysis of 53 studies including 4178 cases and 4590 controls. J Clin Periodontol. 2008 Sep;35(9):754-67. PubMed PMID: 18673406. Epub 2008/08/05. eng.
69. Huttner EA, Machado DC, de Oliveira RB, Antunes AG, Hebling E. Effects of human aging on periodontal tissues. Spec Care Dentist. 2009 Jul-Aug;29(4):149-55. PubMed PMID: 19573041. Epub 2009/07/04. eng.
70. Genco RJ. Current view of risk factors for periodontal diseases. J Periodontol. 1996 Oct;67(10 Suppl):1041-9. PubMed PMID: 8910821. Epub 1996/10/01. eng.
71. Albandar JM. Global risk factors and risk indicators for periodontal diseases. Periodontol 2000. 2002;29:177-206. PubMed PMID: 12102708. Epub 2002/07/10. eng.
72. Ronderos M, Jacobs DR, Himes JH, Pihlstrom BL. Associations of periodontal disease with femoral bone mineral density and estrogen replacement therapy: cross-sectional evaluation of US adults from NHANES III. J Clin Periodontol. 2000 Oct;27(10):778-86. PubMed PMID: 11034127. Epub 2000/10/18. eng.
73. Tezal M, Wactawski-Wende J, Grossi SG, Ho AW, Dunford R, Genco RJ. The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol. 2000 Sep;71(9):1492-8. PubMed PMID: 11022780. Epub 2000/10/07. eng.
74. Lundstrom A, Jendle J, Stenstrom B, Toss G, Ravald N. Periodontal conditions in 70-year-old women with osteoporosis. Swed Dent J. 2001;25(3):89-96. PubMed PMID: 11813450. Epub 2002/01/30. eng.
75. Weyant RJ, Pearlstein ME, Churak AP, Forrest K, Famili P, Cauley JA. The association between osteopenia and periodontal attachment loss in older women. J Periodontol. 1999 Sep;70(9):982-91. PubMed PMID: 10505800. Epub 1999/10/03. eng.
76. Geurs NC, Lewis CE, Jeffcoat MK. Osteoporosis and periodontal disease progression. Periodontol 2000. 2003;32:105-10. PubMed PMID: 12756036. Epub 2003/05/21. eng.
77. Ronderos M, Ryder MI. Risk assessment in clinical practice. Periodontol 2000. 2004;34:120-35. PubMed PMID: 14717859. Epub 2004/01/14. eng.
78. Payne JB, Reinhardt RA, Nummikoski PV, Patil KD. Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women. Osteoporos Int. 1999;10(1):34-40. PubMed PMID: 10501777. Epub 1999/09/29. eng.
79. Yoshihara A, Seida Y, Hanada N, Miyazaki H. A longitudinal study of the relationship between periodontal disease and bone mineral density in community-dwelling older adults. J Clin Periodontol. 2004 Aug;31(8):680-4. PubMed PMID: 15257747. Epub 2004/07/20. eng.
80. Phipps KR, Chan BK, Madden TE, Geurs NC, Reddy MS, Lewis CE, et al. Longitudinal study of bone density and periodontal disease in men. J Dent Res. 2007 Nov;86(11):1110-4. PubMed PMID: 17959906. Epub 2007/10/26. eng.
81. Barr C, Lopez MR, Rua-Dobles A. Periodontal changes by HIV serostatus in a cohort of homosexual and bisexual men. J Clin Periodontol. 1992 Nov;19(10):794-801. PubMed PMID: 1452807. Epub 1992/11/01. eng.
82. Yeung SC, Stewart GJ, Cooper DA, Sindhusake D. Progression of periodontal disease in HIV seropositive patients. J Periodontol. 1993 Jul;64(7):651-7. PubMed PMID: 8366414. Epub 1993/07/01. eng.
83. Alpagot T, Remien J, Bhattacharyya M, Konopka K, Lundergan W, Duzgunes N. Longitudinal evaluation of prostaglandin E2 (PGE2) and periodontal status in HIV+ patients. Arch Oral Biol. 2007 Nov;52(11):1102-8. PubMed PMID: 17586460. Epub 2007/06/26. eng.
84. Gonzalez OA, Ebersole JL, Huang CB. Oral infectious diseases: a potential risk factor for HIV virus recrudescence? Oral Dis. 2009 Jul;15(5):313-27. PubMed PMID: 19364391. Epub 2009/04/15. eng.
85. Cross DL, Smith GL. Comparison of periodontal disease in HIV seropositive subjects and controls (II). Microbiology, immunology and predictors of disease progression. J Clin Periodontol. 1995 Jul;22(7):569-77. PubMed PMID: 7560241. Epub 1995/07/01. eng.
86. Smith GL, Cross DL, Wray D. Comparison of periodontal disease in HIV seropositive subjects and controls (I). Clinical features. J Clin Periodontol. 1995 Jul;22(7):558-68. PubMed PMID: 7560240. Epub 1995/07/01. eng.
87. Robinson PG, Boulter A, Birnbaum W, Johnson NW. A controlled study of relative periodontal attachment loss in people with HIV infection. J Clin Periodontol. 2000 Apr;27(4):273-6. PubMed PMID: 10783842. Epub 2000/04/28. eng.
88. Papapanou PN, Lindhe J. Epidemiology of Periodontal Disease. In: Lindhe J, Lang NP, Karring T, editors. Clinical Periodontology and Implant Dentistry. 5 ed. Oxford, UK: Blackwell Publishing Ltd; 2008. p. 129-79.


Author Information

Aous Dannan, Dr. med. dent
Department of Periodontology, Faculty of Dental Medicine
Syria
aousdannan@yahoo.com

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy